Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

Scientists have made an interesting discovery about a common ED drug. Viagra has the potential to protect people from the ...

Dr. Yoshiteru Shimoide, immunologist and director of the Yoshiteru Shimoide Internal Medicine Clinic in Kagoshima, Japan, has developed RO‑8, the world’s first therapeutic agent designed to ...

Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting its potential as a non-invasive Alzheimer’s therapy. Scientists at the Kunmi ...

A common type of bacteria that causes sinus infections and pneumonia may stay in the eye for many years, potentially increasing a person's risk for developing Alzheimer's, a new study finds.

Scientists show that lecanemab clears amyloid plaques by engaging microglia through its Fc fragment, defining the cellular program behind its therapeutic effect ...

A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...

XPro™ is a next-generation, selective soluble TNF inhibitor designed to selectively neutralize soluble TNF (sTNF) and restore immune homeostasis in the brain, without affecting transmembrane TNF ...

Virtual Memory Clinic Expands Access to Brain Health Screenings for Wellabe Customers Nationwide NEW YORK, NY, UNITED ...

Public drug plans should not cover lecanemab, a drug to slow early-stage Alzheimer's disease, Canada's Drug Agency says in its draft recommendation.

The findings suggest subtle changes in the eye’s outer retina could help spot Alzheimer’s years before memory loss begins.